Leading the Life Sciences Revolution with Jenn Azar, CEO of Stellix

In this episode of Building AI Boston, co-hosts Anna Devere and Kara Peterson sit down with Jenn Azar, CEO of Stellix, a visionary leader helping accelerate innovation at the intersection of science, technology, and human ingenuity. They explore how AI, digital transformation, and Industry 5.0 are reshaping the future of life sciences and drug discovery—from advanced manufacturing to personalized medicine—and how leaders can guide teams through change with empathy, humor, and purpose. Highlights: • How Industry 5.0 is bridging discovery and delivery in life sciences • The digital acceleration of drug discovery and biomanufacturing • Building adaptive, curious teams in a rapidly changing world • Why technology should create more space for human creativity • What it takes to lead with optimism and resilience amid transformation AI isn’t just transforming industry—it’s redefining how science moves from the lab to life. 🌐 BuildingAIBoston.com 🎧 Listen on Spotify 🎥 Watch on YouTube 💼 Learn more about Stellix: https://www.stellix.com 👥 Follow co-hosts: Anna Devere | Kara Peterson #BuildingAIBoston, #AI, #Industry5_0, #DigitalTransformation, #LifeSciencesInnovation, #DrugDiscovery, #Biomanufacturing, #Stellix, #JennAzar, #HumanCenteredAI, #AIinBiotech, #FutureOfWork, #TechWithPurpose, #WomenInAI, #AIBoston, #LeadershipInAI, #ScienceAndTechnology, #AIForGood, #InnovationPodcast, #BostonTech

There are no comments yet.

Please log in to write the first comment.